Nexvet Biopharma (NVET) Priced

Developing biologics for the treatment of pain and inflammation in cats and dogs.

Health Care - Biotechnology

IPO Performance
Latest Trade $3.24 0.00 (0.0%)
First Day Return -11.2%
Return from IPO -67.6%
 
Nexvet Biopharma IPO News more
  • .
IPO Data
IPO File Date 12/30/2014
Offer Price $10.00
Price Range $13.00 - $16.00
Offer Shares (mm) 4.0
Deal Size ($mm) 40
 
IPO Data
IPO Date 02/04/2015
Offer Price $10.00
Price Range $13.00 - $16.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
 
Underwriters
more
Business Overview
Developing biologics for the treatment of pain and inflammation in cats and dogs.
Developing biologics for the treatment of pain and inflammation in cats and dogs.
more
Company Data
Headquarters Dublin, , Ireland
Founded 2010
Employees 21
Website www.nexvet.com
 

Performance vs. IPO Index (IPOUSA)